p. 1-8
Differential expression of retinoic acid receptors in normal and malignant esophageal tissues
Anupam Kumar, Jatinder Kaur, Tushar Kant Chattopadhyay, Meera Mathur and Ranju Ralhan
Abstract
Full Text (IP)
p. 9-18
Cytostatic anticancer drug development
Shea N. Gardner and Michael Fernades
Abstract
Full Text (IP)
p. 19-24
A combination therapy with copper nicotinate complex reduces the adverse effects of 5-fluorouracil on patients with hepatocellular carcinoma
Muhammad A.M. El-Saadani
Abstract
Full Text (IP)
p. 25-35
Transport of SN-38 by the Wild Type of Human ABC Transporter ABCG2 and Its Inhibition by Quercetin, a Natural Flavonoid
Megumi Yoshikawa, Yoji Ikegam, Kazumi Sano, Hisahiro Yoshida, Hideyuki Mitomo, Seigo Sawada and Toshihisa Ishikawa
Abstract
Full Text (IP)
p. 37-57
Conditionally replicating adenoviruses as anticancer agents and ways to improve their efficacy
Dinja Oosterhoff and Victor W. Van Beusechem
Abstract
Full Text (IP)
Laboratory Investigation
p. 59-68
Immuno-neutralization of circulating relaxin does not alter the breast cancer-protective action of parity in MNU-treated rats
Bernard G. Steinetz, O. David Sherwood, Sally Lasano, Lori Horton and Maarten C. Bosland
Abstract
Full Text (IP)
p. 69-78
Selenium is effective in inducing lymphocyte progression through cell cycle in cancer patients: potential mechanisms for its activity
Giovanni Mantovani, Antonio Maccio, Clelia Madeddu, Roberto Serpe, Elena Massa, Giulia Gramignano, Maria Rita Lusso, Nicoletta Curreli and Augusto Rinaldi
Abstract
Full Text (IP)
Short Communication
p. 79-83
Phase II study of OK-432 intrapleural administration followed by systemic cisplatin and gemcitabine for non-small cell lung cancer with pleuritis carcinomatosa
Mizuki Ikehara, Fumihiro Oshita, Rie Susuki, Haruhiro Saitoh, Kouzo Yamada and Kazumasa Noda
Abstract
Full Text (IP)